Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Ventricular Tachycardia, Sudden Cardiac Death
Interventions: Functional Substrate-Only Mapping without VT Induction, Standard-of-Care Mapping/Imaging; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Rett Syndrome
Interventions: computer gaming; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 4 Years to 65 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lung Cancer
Interventions: Breath-Hold PET/CT image set; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Intracranial Embolism, Cerebral Thromboembolism, Carotid Stenosis
Interventions: ARC1779 Injection, Placebo (normal saline); Drug
Lead sponsor: Archemix Corp.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Hackensack, New Jersey • Houston, Texas

Conditions: Osteoarthritis
Interventions: RS-4i Plus; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 89 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Orange, California

Conditions: Peripheral Neuropathy, Low Back Pain
Interventions: MC5-A Scrambler Therapy, MC5-A Scrambler Therapy Sham Device; Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 79 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Epilepsy, Autobiographical Memory
Interventions: Free and Cued Recall Memory. Temporal Sequence and Spatial Memory; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Brain Concussion, Mild Traumatic Brain Injury
Interventions: BrainPulse; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 5 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Boston, Massachusetts • Cincinnati, Ohio • Johnson City, Tennessee

Conditions: Pediatric Obesity, Pediatric Asthma
Interventions: Pro2 - 60% of participant's MIP, Pro2 - 15% of participant's MIP; Device
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Traumatic Brain Injury, Ischemic Stroke, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Acute Anoxic Encephalopathy
Interventions: Indocyanine Green; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia
Interventions: Everolimus; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 2 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Melanoma (Skin)
Interventions: aldesleukin, fowlpox virus vaccine vector, gp100 antigen; Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 16 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Speech Sound Disorder
Interventions: Visual-acoustic biofeedback, Motor-based treatment; Behavioral
Lead sponsor: New York University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Bloomfield, New Jersey • Syracuse, New York

Conditions: Uveal Melanoma
Interventions: Selumetinib, 100mg, Selumetinib, 125mg, Selumetinib, 150mg, Selumetinib, 175mg, Selumetinib, 200mg, Selumetinib, 225mg; Drug
Lead sponsor: Shaheer A. Khan; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: New York, New York • Houston, Texas

Conditions: Abdominal Aortic Aneurysm
Interventions: Contrast enhanced ultrasound; Diagnostic Test
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Blood Loss, Surgical, Postoperative Hemorrhage
Interventions: Wearable optical hemodynamic monitoring device; Device
Lead sponsor: Hemorai Inc; Industry
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Auditory Processing Disorder
Interventions: Communication Counseling, Hearing Aids, Remote Microphones; Behavioral · Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 79 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Glioma, Brain Tumor Adult
Interventions: Functional magnetic resonance imaging (fMRI), Neuropsychological Assessments; Other · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1
Interventions: Selumetinib, Sirolimus; Drug
Lead sponsor: Sarcoma Alliance for Research through Collaboration; Other
Eligibility: 12 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Bethesda, Maryland + 2 more

Conditions: Healthy, Pain
Interventions: Selective Nerve Stimulation (SNS) stimulator device; Device
Lead sponsor: Codman & Shurtleff; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Raynham, Massachusetts

Conditions: Prediction of Extubation Readiness
Interventions: Cardiorespiratory signal acquisition; Other
Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre; Other
Eligibility: Not listed
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 2
States / cities: Detroit, Michigan • Providence, Rhode Island

Conditions: Problem Behavior, Aggression, Self-Injury
Interventions: Functional Communication Training (FCT), Non-Contingent Reinforcement (NCR), Competing Items and Response Blocking, Research Units in Behavioral Intervention (RUBI) protocol; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 3 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Somerset, New Jersey

Conditions: Healthy Subjects
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Concussion, Intermediate
Interventions: BrainPulse; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 18 Years to 28 Years
Enrollment: 353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Laramie, Wyoming

Search by objective public record fields.

Functional Substrate-Only Guided VT Ablation

Technology-supported Motor Rehabilitation for People With Rett Syndrome

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Patient Observational Pain and Activity Survey (POPAS) Study Using RS-4i Sequential Stimulator With Intersperse Technology in Axial Spine and Peripheral Joint Pain

MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain

Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings

Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)

Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma

Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors

Intermittent Selumetinib for Uveal Melanoma

Contrast Enhanced Ultrasound Endoleak Identification and Classification

Study of the Hemorai Vysio Wearable Device for Monitoring Changes Related to Blood Loss in Patients During and After Surgery.

Hearing Aids for Veterans With Functional Hearing Difficulties

Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical Patients

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Selective Nerve Stimulation (SNS) Pilot Study

Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior

Manualized Assessment and Treatment Model of Challenging Behavior

Pulse Oximetry- Performance During Severe Signal Interference

Unblinded Data Collection Study of Concussion Using BrainPulse